Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'
Clicks: 333
ID: 115067
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
333 views
30 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #5 of 8 articles by views in Leukemia & lymphoma
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (30 words).
Try re-searching for a better abstract.
| Reference Key |
g2019leukemiareal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Mele G;Pastore D;Di Renzo N;Fragasso A;Guarini A;Mazza P;Musto P;Pavone V;Tarantini G;Curci P;Falcone AP;Mele A;Miccolis MR;Palazzo G;Palumbo G;Quinto AM;Reddiconto G;Rizzi R;Cascavilla N;Specchia G;Capalbo SF;; |
| Journal | Leukemia & lymphoma |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.